CD24 and medulloblastoma: We identified elevated CD24 levels in all human medulloblastoma subgroups compared to normal cerebellum and normal brain tissue controls in 8 non-overlapping, independent gene expression-profiling studies (p<0.001, Fig 5A and 5B) [5, 42, 44, 45, 63–65].